1933 Industries' AMA Brand Defends Pricing Power as Nevada Cannabis Market Shrinks and Illicit Sales Rise

The environment for Nevada's cannabis industry is tightening, creating a headwind for all players. The regulated market contracted sharply last year, with taxable sales falling to $758 million, a decline of 8.6% from the prior period. This drop in revenue, which also translated to a nearly 9% decrease in state cannabis tax revenue, signals a market where demand is not necessarily falling but where prices are being forced down by intense competition and oversupply. The pressure is not just from licensed operators; a resilient illicit market remains a persistent threat, with state data suggesting it may account for up to a quarter of all marijuana sales in the state. This unlicensed activity cuts directly into tax revenue and creates a pricing floor that licensed businesses struggle to meet.

Against this backdrop of a shrinking legal market and a strong black market, 1933 Industries' financial results reflect the sector-wide squeeze. The company's own revenue for the second quarter of fiscal 2026 was $7.9 million, a drop from the previous year, attributed to declining flower prices and increased competition. Its gross margin fell from 34% to 24%, a clear indicator of the margin pressure across the industry. Yet, within this weak market, the company's Alternative Medicine Association (AMA) brand maintained strong standings, particularly in concentrates and flower. This top-tier position is a critical counterpoint, demonstrating that even in a contracting landscape, a focused brand with quality offerings can hold its ground and remain a key supplier in the Las Vegas market. The challenge now is whether that brand strength can be leveraged to grow market share as the overall pie gets smaller.

Financial Performance: Cost Discipline vs. Revenue Pressure

The company's latest quarterly results show a clear battle between market headwinds and internal cost discipline. Revenue for the second quarter of fiscal 2026 fell to $7.9 million, a decline from $8.4 million a year ago. This drop is directly tied to the contracting Nevada market, with management citing declining flower prices and increased competition as primary drivers.

Yet, the story isn't one of pure deterioration. The company executed significant expense reductions, which helped narrow its losses. Gross profit fell to $1.9 million from $2.8 million, but the gross margin improvement to 24% from 34% is a key signal. This margin gain came from lower license taxes and insurance costs, demonstrating that operational savings were outpacing the revenue decline.

The bottom line reflects this tug-of-war. Despite the revenue drop, net losses narrowed to $0.2 million in the quarter compared to $0.89 million in the prior year. This improvement was driven by the expense cuts, which reduced total expenses to $2.1 million from $3.7 million. In other words, the company is spending less to generate each dollar of revenue, a necessary adjustment in a shrinking market.

The setup here is one of resilience through austerity. The gross margin improvement shows the cost-saving initiatives are working, but they are a defensive measure against a structural revenue pressure. The narrowing net loss is a positive trend, but it does not change the underlying challenge: the company is producing less revenue while trying to maintain its position. The real test will be whether this cost discipline can be sustained as the market continues to contract, or if it will eventually force deeper cuts to growth investments.

Strategic Positioning and Future Catalysts

The company's primary strategic lever is its proprietary Alternative Medicine Association (AMA) brand. In a market defined by price competition, AMA's strength in concentrates and flower provides a critical foothold. This top-tier brand is the company's main asset for maintaining pricing power and market share as the overall legal market shrinks. Its ability to command a premium in a price-sensitive environment is the key to weathering the current storm.

The biggest external risk remains the persistent illicit market, which may account for up to a quarter of all sales in Nevada. This unlicensed activity directly undermines the legal industry's revenue and creates a downward pricing pressure that licensed operators like 1933 Industries must absorb. Compounding this is the potential for regulatory change. State regulators are actively planning to review the tax structure, with a committee examining whether adjustments are needed to boost sales. While the goal is to stabilize the industry, any new rules could introduce further uncertainty or shift the competitive landscape.

For the company's future financial health, the path is clear but narrow. Success depends entirely on its ability to defend and grow AMA's share of a contracting market. The recent gross margin improvement shows cost discipline is working, but that is a defensive play. The real catalyst for a turnaround would be a stabilization or reversal of the statewide sales decline, which is currently among the steepest in the country. Without that, the company's financial resilience will be tested by the ongoing squeeze from both the illicit market and a shrinking legal pie.